Drug Discovery Outsourcing Market with COVID-19 Impact Analysis, By Type (Medical Chemistry Service, and Biology Service), By Drug Type, Therapeutic Area, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2022-2028
REPORT HIGHLIGHT
The Drug Discovery Outsourcing Market size was valued at USD 3,407.1 Million in 2021, expanding at a CAGR of 7.8% from 2022 to 2028.
Drug discovery outsourcing is the process of discovering new drugs or medicines in sectors such as pharmacology, biotechnology, and pharmaceuticals. Drug discovery is a time-consuming procedure, with an extremely low success rate. Various new and small industry players create pharmaceuticals and sell them to the big players so that they can study the results of the trials and determine whether the drugs are useful or not.
Market Dynamics:
Due to companies interacting more and leveraging expertise, it is projected that the market for outsourcing drug discovery would expand. To exploit any proprietary technology, chemicals, and other resources, organizations are forming new strategic partnerships with multiple academic institutions, venture capitalists for finance, and other private or public firms. Growing collaborations between public and private entities have sped up drug discovery, increasing demand for outsourcing drug discovery globally. For instance, in June 2017, Eisai extended its partnership with Charles River Laboratories International, Inc., an early-stage CRO, to discover novel treatments for neurological and tropical diseases. Thus, such collaborations spur the need for identifying better drug candidates, propelling industry development.
The rising incidence rate of metabolic, genetic, and other chronic diseases is expected to provide a lucrative opportunity for market growth. Numerous diseases, including diabetes, cancer, malaria, cardiology, cystic fibrosis, multiple sclerosis, and many more, are currently affecting large numbers of people, necessitating the use of cutting-edge medications. For instance, as per the World Health Organization, more than 11 million people suffered from tuberculosis, which is accounted for around 1.4 million deaths. The number of patients with diabetes is anticipated to increase to 350 million by 2027 due to improper diet, a rising obese population, an aging population, coupled with an inactive lifestyle.
COVID-19 Impact:
The COVID-19 virus is now a significant public health issue. Pharmaceutical businesses have come to the forefront of this crisis and have gained widespread notice. The importance of medication development and discovery has been illustrated by the COVID-19 pandemic. Outsourcing drug research has become essential to creating virus-fighting drugs that work. Exscientia provided proof-of-concept in July 2021 by utilizing its AI platform to create a novel family of inhibitors that target Mpro, also known as 3CLpro, the primary protease enzyme of the COVID-19-causing SARS-CoV-2. By moving the first three entirely AI-designed small molecule therapeutic candidates into clinical trials, Exscientia has established a track record for enhancing and speeding drug discovery. Exscientia has formed partnerships with major pharmaceutical corporations such as Bristol-Myers Squibb, Bayer, Sanofi, and Dainippon Sumitomo, as well as other biotech firms. Thus, Covid-19 will have a significant impact on the global market for Drug Discovery Outsourcing, as the future of many medications under development is dependent on the outcomes of numerous current studies.
Geography Insights:
North America was the market leader in 2021 and is expected to expand throughout the projected period. The regional market's expansion can be attributed to technical improvements, the presence of well-established research infrastructure and significant companies, and increased investments in drug discovery R&D. Outsourcing is no longer only about cutting costs; increased demands for efficiency, quality, and innovation are likely to drive industry growth. During the forecast period, the Asia region is expected to have the quickest CAGR. Because of the availability of competent labor, cheaper costs, a favorable regulatory framework, and high-quality data, the region is emerging as a hub for outsourcing drug discovery activities.
Recent Development:
- In April 2019, Eurofins Discovery Services, a contract research business, introduced DiscoveryOne, a new drug discovery service. The novel technique is beneficial to drug discovery research and preclinical development.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET KEY PLAYERS
- GenScript Biotech Corporation
- Charles River Laboratories International, Inc.
- Curia Inc.
- Dalton Pharma Services
- Evotec SE
- PPD, Inc.
- Oncodesign
- Jubilant Life Sciences Limited
- Eurofins Scientific
- WuXi AppTec
- Laboratory Corporation of America Holdings
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY TYPE
- Medical Chemistry Service
- Biology Service
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY DRUG TYPE
- Small Molecule
- Large Molecules (Biopharmaceuticals)
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY THERAPEUTIC AREA
- Oncology
- Infectious Disease
- Respiratory Disease
- Cardiovascular
- Gastrointestinal
- Others
GLOBAL DRUG DISCOVERY OUTSOURCING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Drug Discovery Outsourcing Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by Drug Type
2.1.3. Market Snippet by Therapeutic Area
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. Drug Discovery Outsourcing Key Market Trends
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. Drug Discovery Outsourcing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Drug Discovery Outsourcing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Drug Discovery Outsourcing Market Landscape
6.1. Market Share Analysis, 2021
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Drug Discovery Outsourcing Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2021 & 2028 (%)
7.1.2. Medical Chemistry Service
7.1.3. Biology Service
8. Drug Discovery Outsourcing Market – By Drug Type
8.1. Overview
8.1.1. Segment Share Analysis, By Drug Type, 2021 & 2028 (%)
8.1.2. Small Molecule
8.1.3. Large Molecules (Biopharmaceuticals)
9. Drug Discovery Outsourcing Market – By Therapeutic Area
9.1. Overview
9.1.1. Segment Share Analysis, By Therapeutic Area, 2021 & 2028 (%)
9.1.2. Oncology
9.1.3. Infectious Disease
9.1.4. Respiratory Disease
9.1.5. Cardiovascular
9.1.6. Gastrointestinal
9.1.7. Others
10. Drug Discovery Outsourcing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.2.5. North America Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.2.6. North America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2017 - 2028 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2017 - 2028 (US$ Million)
11. Key Vendor Analysis
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. GenScript Biotech Corporation
11.2.2. Charles River Laboratories International, Inc.
11.2.3. Curia Inc.
11.2.4. Dalton Pharma Services
11.2.5. Evotec SE
11.2.6. PPD, Inc.
11.2.7. Oncodesign
11.2.8. Jubilant Life Sciences Limited
11.2.9. Eurofins Scientific
11.2.10. WuXi AppTec
11.2.11. Laboratory Corporation of America Holdings
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
